Stocks›Basic Materials›AKAN

AKAN

Name: AlgoThesis
Author: algothesis

AKANDA CORP.

NasdaqResearch view

Basic Materials · Medicinal Chemicals & Botanical Products · SEC EDGAR FY 2024-12-31

Price history

Interactive · live data via TradingView

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2024-12-31

Revenue$836,664

Net Income$-4.1M

Gross Profit$208,382

Oper Income$-4.4M

EPS (dil)$-3.93

Rev/sh$0.42

FCF/sh$-3.06

Book/sh$2.16

Cash/sh$1.94

40+ fundamentals from SEC EDGAR (public domain) — deeper than a typical screener's ratio table.

Revenue & Earnings — fiscal year

$2,062

2020

$41,431

2021

$2.6M

2022

$423,683

2023

$836,664

2024

Financials — annual

SEC EDGAR · last 5 FY

USD	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$2,062	$41,431	$2.6M	$423,683	$836,664
Gross Profit	$-58,176	$-1,591	$3.3M	$59,337	$208,382
Operating Income	$-1.7M	$-2.6M	$-20.2M	$-3.7M	$-4.4M

Deep dive

Computed from the SEC EDGAR multi-year statements

Operating leverage — margins

GrossOperatingNet

COMMUNITY · $AKAN0 theses

POST YOUR TAKE →

Related Stocks

Loading peers…

Ask AI about AKAN Build basket with AKAN Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.

AKAN AKANDA CORP. Stock — fundamentals, financials & AI research · AlgoThesis